Registry for People with Multiple Sclerosis
Multiple Sclerosis Implementation Network (Registry)
Recruiting
Observational Study
Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- The University of Texas Health Science Center, Houston · Other
Who this trial is looking for
This trial is looking for people who have been diagnosed with Multiple Sclerosis (MS) and can speak and understand English comfortably. Participants will help improve MS care and quality of life by contributing to a database that collects their health information.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with Multiple Sclerosis
- I can speak and understand English comfortably
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* diagnosed with Multiple Sclerosis
* can speak and understand English comfortably
Contacts